Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

First subject enrolled in phase III study of TRC-101 in chronic kidney disease

Sep. 29, 2017

The Brigham and Women's Hospital identifies SMOC2 inhibitors

Sep. 26, 2017

FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder

Sep. 14, 2017

Bayer enters kidney disease collaboration with Vanderbilt University Medical Center

Sep. 12, 2017

MK-3866 studied in patients with impaired renal function

Sep. 12, 2017

Avadel enters license agreement for U.S. and Canadian rights to Noctiva

Sep. 6, 2017

Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism

Sep. 5, 2017

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Sep. 1, 2017

Apricus resubmits Vitaros NDA

Aug. 30, 2017

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...